Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 26, 2012Cell Death and DiseaseOpen Access

Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

PKPedram KharazihaPRPatricia Q. RodriguezQLQiao Li

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kharaziha et al. (2012) studied this question.

synapsesocial.com/papers/6a952bf966ca20f6f97cf681https://doi.org/10.1038/cddis.2012.1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nonreceptor Tyrosine Kinases in Prostate2007 · 115 citations
  2. 2A tyrosine kinase profile of prostate carcinoma.1996 · 210 citations
  3. 3High Frequency of Mutations of the <i>PIK3CA</i> Gene in Human Cancers2004 · 3,473 citations
  4. 4Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)1999 · 1,091 citations